VI NEXT Trademark

Trademark Overview

On Friday, March 25, 2016, a trademark application was filed for VI NEXT with the United States Patent and Trademark Office. The USPTO has given the VI NEXT trademark a serial number of 86952882. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, August 2, 2024. This trademark is owned by Regeneron Pharmaceuticals, Inc.. The VI NEXT trademark is filed in the Natural Agricultural Products category with the following description:

Genetically modified animals with genetically modified immune system components
vi next

General Information

Serial Number86952882
Word MarkVI NEXT
Filing DateFriday, March 25, 2016
Status710 - CANCELLED - SECTION 8
Status DateFriday, August 2, 2024
Registration Number5387305
Registration DateTuesday, January 23, 2018
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, August 15, 2017

Trademark Statements

Description of MarkThe mark consists of the words "VI NEXT" in a stylized font with an antibody design between the words "VI" and "NEXT".
Indication of Colors claimedColor is not claimed as a feature of the mark.
NOT AVAILABLETHE ANTIBODY SYMBOL
Goods and ServicesGenetically modified animals with genetically modified immune system components

Classification Information

International Class031 - Agricultural, horticultural and forestry products and grains not included in other classes; live animals; fresh fruits and vegetables; seeds, natural plants and flowers; foodstuffs for animals; malt.
US Class Codes001, 046
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, August 2, 2024
Primary Code031
First Use Anywhere DateWednesday, April 20, 2016
First Use In Commerce DateWednesday, April 20, 2016

Trademark Owner History

Party NameRegeneron Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591
Party NameRegeneron Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591
Party NameRegeneron Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591

Trademark Events

Event DateEvent Description
Wednesday, March 30, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 29, 2016NEW APPLICATION ENTERED
Wednesday, October 26, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, November 15, 2016NON-FINAL ACTION E-MAILED
Thursday, March 31, 2016NOTICE OF DESIGN SEARCH CODE E-MAILED
Monday, May 2, 2016ASSIGNED TO EXAMINER
Saturday, May 7, 2016PRIORITY ACTION WRITTEN
Saturday, May 7, 2016PRIORITY ACTION E-MAILED
Saturday, May 7, 2016NOTIFICATION OF PRIORITY ACTION E-MAILED
Wednesday, October 26, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 27, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, November 15, 2016NON-FINAL ACTION WRITTEN
Tuesday, November 15, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, June 28, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 26, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 15, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, May 11, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, June 8, 2017ASSIGNED TO LIE
Friday, June 9, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, June 9, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, July 7, 2017LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, August 15, 2017PUBLISHED FOR OPPOSITION
Monday, December 4, 2017TEAS STATEMENT OF USE RECEIVED
Tuesday, December 19, 2017NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, January 23, 2018REGISTERED-PRINCIPAL REGISTER
Thursday, July 14, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, October 10, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, December 4, 2017USE AMENDMENT FILED
Friday, December 15, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, December 18, 2017STATEMENT OF USE PROCESSING COMPLETE
Monday, December 18, 2017ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, July 14, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, July 14, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, January 23, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, August 2, 2024CANCELLED SEC. 8 (6-YR)

Related Keywords

next genetically modified components system animals immune